QAT

Brain Trauma Assessment Test

Product code
QAT
Device name
Brain Trauma Assessment Test
Device class
Class 2
21 CFR
21 CFR 866.5830
Medical specialty
Immunology
Marketing pathway
510(K)
Flag
Third-party review eligible
510(k) clearances (last 3 years)
3
Summaries archived here
3 (direct download)
510(k) clearances (all years, FDA)
6 (all years; only the last 3 years are listed here)

FDA classification definition

Intended for in vitro diagnostic use as an aid in the evaluation of patients with suspected mild traumatic brain injury (TBI) in conjunction with other clinical information to assist in determining the need for radiologic (e.g., CT, MR) head imaging per current standard of care

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (3)

Last three years. Most recent: 2024-05-01.

NumberDecision dateApplicantDevice nameSummary
K2402792024-05-01bioMerieux, Inc.VIDAS TBI (GFAP, UCH-L1)PDF
K2341432024-03-27Abbott Point of Carei-STAT TBI Cartridge with the i-STAT Alinity SystemPDF
K2326692023-09-29Abbott LaboratoriesTBIPDF

3 summaries are archived here for direct download.

Official FDA classification page: QAT
Classification and pathway per current FDA publications. Data from openFDA (CC0).